Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2005-05-10
2005-05-10
Sykes, Angela D. (Department: 3762)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S005010, C604S006110, C604S006160, C604S006060, C604S065000, C604S066000, C604S067000, C210S645000, C210S646000, C210S649000, C210S650000, C210S651000, C210S090000
Reexamination Certificate
active
06890315
ABSTRACT:
A method and apparatus for ultrafiltration of blood operating by removing blood from a peripheral blood vessel at a rate of less than two percent of total cardiac output of a patient, extracting fluid at a rate of 0.1 liter to 1.0 liters per hour while retaining cells and proteins in the blood, and returning the concentrated blood to a secondary blood vessel is disclosed. Blood is removed and returned using small gage needles. As a pump circulates blood from the patient, a filter removes ultrafiltrate from the blood using duty cycle or pump control, and a transparent container collects the removed fluid.
REFERENCES:
patent: 4080958 (1978-03-01), Bregman et al.
patent: 4086924 (1978-05-01), Latham, Jr.
patent: 4619639 (1986-10-01), Nose et al.
patent: 4657529 (1987-04-01), Prince et al.
patent: 4784768 (1988-11-01), Mathieu
patent: 4828543 (1989-05-01), Weiss et al.
patent: 4936980 (1990-06-01), Yoshimichi et al.
patent: 5114580 (1992-05-01), Ahmad et al.
patent: 5211849 (1993-05-01), Kitaevich et al.
patent: 5312550 (1994-05-01), Hester
patent: 5366630 (1994-11-01), Chevallet
patent: 5476451 (1995-12-01), Ensminger et al.
patent: 5536237 (1996-07-01), Prince et al.
patent: 5685989 (1997-11-01), Krivitski et al.
patent: 5707086 (1998-01-01), Treu et al.
patent: 5725776 (1998-03-01), Kenley et al.
patent: 5730712 (1998-03-01), Falkvall et al.
patent: 5792367 (1998-08-01), Mattisson et al.
patent: 5830365 (1998-11-01), Schneditz
patent: 5906589 (1999-05-01), Gordon et al.
patent: 5910252 (1999-06-01), Truitt et al.
patent: 6090048 (2000-07-01), Hertz et al.
patent: 6299575 (2001-10-01), Bolling
patent: 6387037 (2002-05-01), Bolling et al.
patent: 6390969 (2002-05-01), Bolling et al.
patent: 20010016699 (2001-08-01), Burbank et al.
patent: 20010037079 (2001-11-01), Burbank et al.
patent: 20010041892 (2001-11-01), Burbank et al.
patent: 20020068015 (2002-06-01), Polaschegg et al.
patent: 20020085951 (2002-07-01), Gelfand et al.
patent: 20020103453 (2002-08-01), Burbank et al.
patent: 20020147423 (2002-10-01), Burbank et al.
patent: 0 274 178 (1988-07-01), None
patent: 0 990 444 (2000-04-01), None
patent: 1 583 023 (1981-01-01), None
Strife et al, “Experience With a Low Volume Ultrafiltration Cell in Small Children,” Clinical Nephrology vol. 8:No. 3, pp. 410-413 (1977).
Strife, C.F. et al, “Experience With a Low Volume Ultrafiltration Cell in Small Children,” Clinical Nephrology 8:410-413 (1977).
Lauer, A. et al, “Continuous Arteriovenous Hemofiltration in the Critically Ill Patient, Clinical Use and Operational Characteristics,” Annals of Internal Medicine 99:455-460 (1983).
Verbanck, J. et al, “Pure Ultrafiltration by Repeated Puncture of a Peripheral Arm-Vein as Treatment of Refratory Edema” (Case Report), The International Journal of Artificial Organs, vol. 3, No. 6 (1980), pp 342-343.
Silverstein et al, “Treatment of Severe Fluid Overload by UItrafiltration,” The New England Journal of Medicine, vol. 291, No. 15, Oct. 10, 1974, pp. 747-751.
Blake, P. et al, “Refractory Congestive Heart Failure: Overview and Application of Extracorporeal Ultrafiltration,” Critical Care Nephrology,Advances in Renal Replacement Therapy,vol. 3, No. 2 (Apr. 1966), pp. 166-173.
Civati G. et al, “Haemofiltration Without Substitution Fluid,” Proc. EDTA-ERA, vol. 21 (1984), pp. 441-446.
Jenkins, R.D. et al, “The Use of Continuous Arteriovenous Hemofiltration With Hemodialysis in a Newborn,” Draft #6, Personal Communication, 1985 (6 pages).
Jacobs, C. et al, “Continuous Arteriovenous Hemofiltration,” Replacement of Renal Function By Dialysis, 4thEd., (1996) pp. 391-397.
Gupta, B.B. et al, “High Shear Rate Hemofiltration: Influence of Fiber Dimensions and Shear Rates,” Artificial Organs, International Society for Artificial Organs, vol. 13(2) (1989), pp. 97-102.
Rimondini, A. et al, “Hemofiltration as Short-Term Treatment for Refractory Congestive Heart Failure,” The American Journal of Medicine, vol. 83, Jul. 1987, pp 43-48.
Donato, L. et al, “Treatment of End-Stage Congestive Heart Failure by Extracorporeal Ultrafiltration,” The American Journal of Cardiology, vol. 59 (Feb. 1, 1987), pp. 379 and 380.
L'Abbate, A. et al, “Ultrafiltration: A Rational Treatment for Heart Failure,” Cardiology 1989; 76:384-390.
Chen, Y. et al, “Direct Peripheral Venopuncture: Another New Choice of Temporary Vascular Access” (Case Report), Renal Failure, 22(3), 369-377 (2000).
Piergiuseppe Agostoni et al., “Sustained Improvement in Functional Capacity After Removal of Body Fluid With Isolated Ultrafiltration in Chronic Cardiac Insufficiency: Failure of Furosemide to Provide the Same Result”, Mar. 1994, The American Journal of Medicine, vol. 96, pp. 191-199.
Daniel Goldstein et al., “Venoarterial Shunting for the Treatment of Right Sided Circulatory Failure After Left Ventricular Assist Device Placement”, ASAIO Journal 1997, pp. 171-176.
Michael Berkoben et al., “Hemodialysis Vascular Access”, pp. 41-57.
Allan Lauer, “Continuous Arteriovenous Hemofiltration in the Critically Ill Patient”, pp. 455-460.
A. L'Abbate et al., “Ultrafiltration: A Rational Treatment for Heart Failure”, Cardiology 1989, pp. 384-390.
Yung-Chang Chen et al., “Direct Peripheral Venopuncture: Another New Choice of Temporary Vascular Access”, pp. 369-377.
James Cimino et al., “Simple Venipuncture For Hemodialysis”, The New England Journal of Medicine, Sep. 20, 1962, pp. 608-609.
Drukker et al., “Replacement of Renal Function by Dialysis”, pp. 334-379.
Andrea Rimondini et al., “Hemofiltration as Short-Term Treatment for Refractory Congestive Heart Failure”, Jul. 1987, The American Journal of Medicine, vol. 83, pp. 43-48.
Marc Silverstein et al., “Treatment of Severe Fluid Overload by Ultrafiltration”, Volumne 291, No. 15, Oct. 10, 1974, pp. 747-751.
Jonathan D. Sackner-Bernstein, MD et al., “How Should Diuretic-Refractory, Volume-Overloaded Heart Failure Patients Be Managed?” The Journal of Invasive Cardiology, vol. 15, No. 10 (Oct. 2003), pp. 585-590.
Brian E. Jaski, MD et al., “Peripherally Inserted Veno-Venous Ultrafiltration for Rapid Treatment of Volume Overloaded Patients”, Journal of Cardiac Failure, vol. 9, No. 3, (Jun. 2003), pp. 227231.
Gelfand Mark
Levin Howard R.
O'Mahony John
Polaschegg Hans-Dietrich
CHF Solutions Inc.
Deak Leslie
Nixon & Vanderhye P.C.
Sykes Angela D.
LandOfFree
Method and apparatus for vein fluid removal in heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for vein fluid removal in heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for vein fluid removal in heart failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3426114